Closed · RFA-OD-14-005 · CFDA 93.113;93.121;93.172;93.173;93.213;93.233;93.242;93.273;93.279;93.286;93.307;93.350;93.351;93.361;93.393;93.394;93.395;93.396;93.399;93.837;93.838;93.839;93.846;93.847;93.853;93.855;93.856;93.859;93.865;93.866;93.867;93.879 · Discretionary
NIH Research Evaluation and Commercialization Hub (REACH) Awards (U01)
Federal grant opportunity posted by National Institutes of Health, cataloged on Grants.gov.
- up to $1M
- Award range
- Closed
- Status
- June 26, 2014
- Close date
- -
- Expected awards
The verdict
NIH Research Evaluation and Commercialization Hub (REACH) Awards (U01) is a closed discretionary listing from National Institutes of Health that offered Up to $1,000,000. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 12,419 other opportunities from National Institutes of Health.
- up to $1M
- award range
- Closed
- application status
- 93.113;93.121;93.172;93.173;93.213;93.233;93.242;93.273;93.279;93.286;93.307;93.350;93.351;93.361;93.393;93.394;93.395;93.396;93.399;93.837;93.838;93.839;93.846;93.847;93.853;93.855;93.856;93.859;93.865;93.866;93.867;93.879
- CFDA program
- 12,419
- other opportunities from National Institutes of Health
Archived opportunity record
NIH Research Evaluation and Commercialization… is closed (last close June 26, 2014). Check the agency catalog for replacement NOFOs. National Institutes of Health still indexes 12,419 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed June 26, 2014
Est. Total Funding
$9,000,000
Instrument
Cooperative Agreement
Description
The NIH Research Evaluation and Commercialization Hub (REACH) program will support proof-of-concept centers (Hubs) that facilitate and accelerate the translation of biomedical innovations into commercial products that improve patient care and enhance health. The REACH Hubs will provide qualified institutions with the initial investment and resources to nurture innovators to develop high priority early-stage technologies within the NIHs mission by providing: (1) infrastructure for identifying the most promising technologies, (2) funding for product definition studies (e.g. feasibility studies, prototype development, or proof-of-concept studies), (3) coordinated access to expertise in areas required for early stage technology development (including scientific, regulatory, reimbursement, business, legal, and project management), and (4) skills development and hands-on experience in entrepreneurism. Establishing public-private partnerships and providing additional non-federal funds will be critical for success.
Multi-door applicant board · 3 Grants.gov types
Grants.gov prints 3 distinct applicant types for NIH Research Evaluation and Commercialization… (Public / state-controlled institutions of higher education; Private institutions of higher education; Others (see official listing text)). Filter fit against the official announcement before drafting. The extract does not mark applicant cost-sharing as required. Instrument: Cooperative Agreement. Funding-activity codes span Education · Environment · Food and Nutrition · Health · Income Security and Social Services (ED;ENV;FN;HL;ISS). Only 256 other National Institutes of Health listings share this exact eligibility-code string (2% of 12,420).
- Code 06
- Public / state-controlled institutions of higher education
- Code 20
- Private institutions of higher education
- Code 25
- Others (see official listing text)
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
NIH OER Webmaster FBOWebmaster@OD.NIH.GOV
More from National Institutes of Health
Validation Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U54 Clinical Trials Not Allowed)
Logistics Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U24 Clinical Trials Not Allowed)
Development and Testing of a Multi-use Frameworks Playbook for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U01 Clinical Trial Not Allowed)
PRIMED-AI: Data-to-Model Academic-Industrial Partnerships (D2M-AIP) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (UG3/UH3 Clinical Trial Optional)
Model-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (UG3/UH3, Clinical Trial Optional)
What to do next
NIH Research Evaluation and Commercialization… is closed; use the parent program and agency catalog for the next funding cycle.
- Browse open federal opportunities in the same category when this listing is closed. Open opportunities
- Look up CFDA 93.113;93.121;93.172;93.173;93.213;93.233;93.242;93.273;93.279;93.286;93.307;93.350;93.351;93.361;93.393;93.394;93.395;93.396;93.399;93.837;93.838;93.839;93.846;93.847;93.853;93.855;93.856;93.859;93.865;93.866;93.867;93.879 across all indexed listings before you commit to this opportunity alone. Eligibility finder
- National Institutes of Health lists 12,419 other indexed opportunities on PlainGrants. Agency catalog
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |